FindMyKOL

Brian Rood, MD

Enriched profile

Director, Clinical Neuro-Oncology; Medical Director, Brain Tumor Institute · Children's National Hospital

ORCID↗NPI↗
✓ Itemized profile
Region🇺🇸 Washington, DC · Northeast · United StatesSpecialtyHematology / OncologyFocusGlioma Diagnosis and Treatment+4
Active KOLFindMyKOL type: RegionalLatest publication2026Online presenceverified 2026Payments2023–2025NIH funding2007–2011

Brian Rood is Director, Clinical Neuro-Oncology; Medical Director, Brain Tumor Institute at Children's National Hospital. OpenAlex indexes 143 publications with 3,735 citations (h-index 30); ClinicalTrials.gov lists 2 registered studies with this person as an investigator.

Data verified 25 Oct 2026

Overview

Updated 27 Oct 2026

Brian Rood, MD, is Director, Clinical Neuro-Oncology at Children's National Hospital. The public record shows 143 publications with 3,735 citations (h-index 30), centered on Glioma Diagnosis and Treatment, Neuroblastoma Research and Treatments, Cancer Genomics and Diagnostics. It also documents an investigator role on 2 registered clinical trials, industry payments reported by 2 companies, 1 NIH-funded awards (2007–2011).

  • Most recent indexed publication: 2026 · The Journal of experimental medicine
  • Top research focus: Glioma Diagnosis and Treatment
  • 2 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 2 companies

Generated from the cited public record · current as of 27 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Neuro-Oncology / Glioma1 trialMedulloblastoma1 trialEpendymoma1 trialRhabdoid Tumor1 trialPinealoma1 trialPica1 trialCentral Nervous System Neoplasms1 trialNervous System Neoplasms1 trialLeukemia (AML/ALL/CML/CLL)

Research focus

OpenAlex concept fingerprint
Glioma Diagnosis and TreatmentNeuroblastoma Research and TreatmentsCancer Genomics and DiagnosticsAdvanced Proteomics Techniques and ApplicationsAcute Lymphoblastic Leukemia research

Drugs & molecules

across trials, industry payments and publications
Ojemdageneric · TovorafenibClinical trials—Industry payments1Publications—

Works with

trial sponsors and companies reporting payments
Children's National Research InstituteClinical trials1Industry payments—Day One BiopharmaceuticalsClinical trials—Industry payments1Illumina, Inc.Clinical trials—Industry payments1Pediatric Brain Tumor ConsortiumClinical trials1Industry payments—

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
143publications

Distinct works indexed by OpenAlex, matched via ORCID; 8 in PubMed.

3,735citations

Total citations across indexed works.

30h-index

Hirsch index (OpenAlex). i10-index 50.

Clinical & industry

trials, payments and federal funding
2clinical trials

Investigator role on registered studies.

View trials ↓
2companies · 2023–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
1NIH grants · 2007–2011

Federally funded research awards.

View funding ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 26 Oct 2026

Listed as an investigator on 2 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 26 Oct 2026

2 companies reported payments to CMS in program years 2023–2025. These are public disclosures, not judgments. The latest:

NIH funding

Updated 26 Oct 2026

1 NIH research award on record, funded 2007–2011 per NIH RePORTER. The latest:

Congress activity

Updated 26 Oct 2026

6 congress contributions (2014–2024) across AACR, ASTRO per OpenAlex. The most recent:

Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.

Publications

Updated 26 Oct 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Network

Updated 26 Oct 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Roger J. Packer49Samuel Rivero-Hinojosa23Javad Nazarian22Yanxin Pei20Tobey J. MacDonald20Najiba Murad19Samuel Rivero-Hinojosa17Adam Cain Resnick17Christopher A. Lazarski16Jerome A. Staal15Kristy J. Brown15Yuankun Zhu14Eugene I. Hwang14Paul A. Northcott14Marcel Kool14Heather Gordish‐Dressman14Michael D. Taylor14Ling San Lau13Stefan Michael Pfister13Lindsay Baker Kilburn13Mojca Stampar13Sabine Mueller13Phillip B. Storm11Jo Lynne Rokita10Catherine M. Bollard10Ulrich Schüller10Mateusz Koptyra10Konstantin Okonechnikov9Jena Lilly9Dominique Leprince9Melanie Grant9Ian F. Pollack9Peng Zhang9Huizhen Zhang9Angela Jae Waanders8Charles G. Eberhart8Amanda G. Paulovich8Adam Kraya8Pan Zheng8Komal S. Rathi8

Online presence

Updated 26 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/brian-rood-md

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 26 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record

Editorial & leadership roles

journal and society appointments

Secondary affiliations

appointments beyond the home institution

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.